Frazier Life Sciences IX, L.P. — Form D
Frazier Life Sciences IX, L.P. of SEATTLE, WA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-11-01. The offering totals $418.9M, of which $418.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-11-01
- Form: D
- Accession: 0001720320-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $418.9M
- Amount sold: $418.9M
- Investors: 55
- Date of first sale: 2017-10-31
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-297918
Issuer
- Name: Frazier Life Sciences IX, L.P.
- CIK: 0001720320
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 601 UNION STREET, SEATTLE, WA, 98101
- Phone: 206-621-7200
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| N/A FHMLS IX, L.L.C. | Executive Officer | Seattle, WA |
| N/A FHMLS IX, L.P. | Executive Officer | Seattle, WA |
| Patrick J Heron | Executive Officer | Menlo Park, CA |
| James N Topper | Executive Officer | Cranbury, NJ |
| Daniel J Estes | Promoter | Palo Alto, CA |
| N/A N Frazier Management, L.L.C. | Promoter | Seattle, WA |
More